U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840990) titled 'Cross-linked CMC and Silk Proteins in Corneal Re-epithelization' on Feb. 18.
Brief Summary: Data analyses and revision of the corneal re-epithelization in patients who underwent either PRK (Photorefractive Keratectomy), CXL (Corneal Cross-Linking), PTK (phototherapeutic keratectomy), or experienced a corneal abrasion. A novel ophthalmic solution containing cross-linked CMC (CX-CMC) and Silk Proteins (SP) has been made available on the market. Both molecules have been widely studied for their wound healing properties in the ophtalmic field. This new ophthalmic solution is the first on the market formulated with a CX-CMC and SP.
Stud...